ASPG and neoplasm: Altered transporter activity might lead to increased efflux or reduced influx of glutamine in tumor cells, resulting in decreased intracellular and consequently plasma glutamine levels (51); 4) Immune system modulation: Asparaginase not only affects tumor cell metabolism but also impacts the immune system, which may be a significant consumer of glutamine during activation (52).